Mary Anne Heino is the Chief Executive Officer of Lantheus Holdings Inc., a position she has held since 2017. With a robust background in the healthcare industry, Heino has been instrumental in steering Lantheus towards significant growth and innovation. Prior to joining Lantheus, she served as President of Bayer HealthCare Pharmaceuticals' Diagnostic Imaging Business, where she played a pivotal role in expanding the company's global footprint. Her leadership experience also includes a tenure at Eastman Kodak as Senior Vice President and General Manager, where she managed the Health Group, demonstrating her capability to drive strategic initiatives in complex sectors. Under Heino's leadership, Lantheus has seen remarkable progress, particularly in the development and commercialization of diagnostic imaging and therapeutic products. She has been a driving force behind the company's focus on precision medicine, notably with the successful launch of PYLARIFY, a PSMA-targeted PET imaging agent for prostate cancer. Her strategic vision has not only enhanced Lantheus' product portfolio but also strengthened its position in the competitive landscape of medical diagnostics. Heino's commitment to advancing healthcare solutions is evident in her active engagement with industry associations and her contributions to various boards, reflecting her dedication to the broader healthcare community. As CEO, Mary Anne Heino continues to lead Lantheus with a clear focus on innovation, patient care, and sustainable growth. Her leadership style emphasizes collaboration and a patient-centric approach, which has fostered a dynamic and inclusive corporate culture at Lantheus. Heino's foresight in navigating market challenges and her ability to capitalize on emerging opportunities have solidified her reputation as a transformative leader in the healthcare industry. Her ongoing efforts are geared towards ensuring that Lantheus remains at the forefront of medical imaging and radiopharmaceuticals, delivering cutting-edge solutions that meet the evolving needs of patients and healthcare providers worldwide.